Back to today’s briefing

Story perspectives

Revolutionary AI Models Transform Drug Discovery Landscape

4/15/2025

30 3

Summary

Story summary

On April 14, 2025, a groundbreaking deep learning model named GraphBAN was unveiled by UM researchers, promising to revolutionize protein interaction predictions and streamline drug discovery. In a parallel move, Japan's PRISM BioLab joined forces with Elix to fuse AI with peptide technology, while the FDA's initiative to replace animal testing with AI simulations sent medical AI stocks soaring.

1 of 1

Story summary

On April 14, 2025, a groundbreaking deep learning model named GraphBAN was unveiled by UM researchers, promising to revolutionize protein interaction predictions and streamline drug discovery. In a parallel move, Japan's PRISM BioLab joined forces with Elix to fuse AI with peptide technology, while the FDA's initiative to replace animal testing with AI simulations sent medical AI stocks soaring.